Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient

Kidney International

Volumn 56, Issue 1, 1999, Pages 306-317

  Rodriguez, Mariano ^a   Caravaca, Francisco ^b   Fernandez, Elvira ^b   Borrego, Maria J ^b   Lorenzo, Victor ^b   Cubero, Juan ^b   Martin Malo, Alejandro ^b   Betriu, Angels ^b   Jimenez, Alejandro ^b   Torres, Armando ^b   Felsenfeld, Arnold J ^b  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b NONE

Author keywords

Calcium; Dialysis; Hyperparathyroidism; Parathyroid hormone

Indexed keywords

CALCITRIOL; CALCIUM ION; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HEMODIALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PARATHYROID FUNCTION; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; SPAIN;

EID: 0033031202     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00538.x     Document Type: Article

References (10)

1. SLATOPOLSKY E, WEERTS C, THIELAN J, HORST R, HARTER H, MARTIN KJ: Marked suppression of secondary hyperparathyroidism by intravenous administration of 1, 25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest 74:2136-2143, 1984
2. QUARLES LD, YOHAY DA, CARROLL BA, SPRITZER CE, MINDA SA, LOBAUGH BL: Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD. Kidney Int 45:1710-1721, 1994
3. LEVINE BS, SONG M: Pharmacokinetics and efficacy of pulse oral versus intravenous calcitriol in hemodialysis patients. J Am Soc Nephrol 7:488-496, 1996
4. GALLIENI M, BRANCACCIO D, PADOVESE P, ROLLA D, BEDANI P, COLANTONIO G, BRONZIERI C, BAGNI B, TAROLO G: Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients. Kidney Int 42:1191-1198, 1992
5. KITAOKA M, FUKAGAWA M, OGATA E, KUROKAWA K: Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients. Kidney Int 46:1110-1117, 1994
6. MENDES V, JORGETTI V, NEMETH J, LAVERGNE A, LECHARPENTIER Y, DUBOST C, COURNOT-WITMER C, BOURDON R, BOURDEAU A, ZINGRAFF J, DRUEKE T: Secondary hyperparathyroidism in chronic haemodialysis patients: A clinico-pathological study. Proc Eur Dial Transplant Assoc 20:731-738, 1983
7. GAGNE ER, UREÑA P, LEITE-SILVA S, ZINGRAFF J, CHEVALIER A, SARFATI E, DUBOST C, DRUEKE TB: Short and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients. J Am Soc Nephrol 3:1008-1017, 1992
8. FUKUDA N, TANAKA H, TOMINAGA Y, FUKAGAWA M, KUROKAWA K, SEINO Y: Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92:1436-1443, 1993
9. PATEL SR, KE HQ, HSU CH: Regulation of calcitriol receptor and its mRNA in normal and renal failure rats. Kidney Int 45:1020-1027, 1994
10. RODRIGUEZ M, FELSENFELD AJ, WILLIAMS C, PEDERSON JA, LLACH F: The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients. J Am Soc Nephrol 2:1014-1020, 1991